BDBM600075 5-{4-amino-5-[(3,3-difluoroazetidin- 1-yl)methyl]pyrrolo[2,1-f][1,2,4]- triazin-7-yl}-2-chloro-4-fluoro-N- [(3R,4S)-4-fluoro-1-[(2R)-3,3,3- trifluoro-2-hydroxy-2-methyl- propanoyl]pyrrolidin-3-yl]benzamide::US11618753, Example 1313

SMILES C[C@@](O)(C(=O)N1C[C@H](F)[C@@H](C1)NC(=O)c1cc(-c2cc(CN3CC(F)(F)C3)c3c(N)ncnn23)c(F)cc1Cl)C(F)(F)F

InChI Key InChIKey=QLYYEEJUOWPBDG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 600075   

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM600075(US11618753, Example 1313 | 5-{4-amino-5-[(3,3-difl...)
Affinity DataIC50: 2.10E+3nMAssay Description:A solution was prepared containing 0.2 nM Anti GST-Tb (Cisbio, 61GSTTLB), 90.6 nM probe and 1 nM His-GST-TVMV-hRIPK1(1-324) in FRET Buffer (20 mM HEP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2023
Entry Details
Go to US Patent